Related Experiment Video
Updated: May 2, 2026

Utilizing a Cranial Window to Visualize the Middle Cerebral Artery During Endothelin-1 Induced Middle Cerebral Artery Occlusion
Published on: February 22, 2013
Asciminib Use Highlighting Underlying Moyamoya Disease: A Case Report
Saloni Savani1, Arpita Pawa1, Naved Salim2
1Internal Medicine, Willis-Knighton Health System, Shreveport, USA.
A patient with chronic myeloid leukemia (CML) developed Moyamoya syndrome after starting asciminib therapy. Symptoms improved after discontinuing the drug, suggesting a potential link and the need for caution.
Area of Science:
- Neurology
- Oncology
- Pharmacology
Background:
- Moyamoya disease (MMD) is a rare cerebrovascular condition characterized by progressive stenosis of intracranial arteries.
- Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm often treated with tyrosine kinase inhibitors.
- Asciminib is an allosteric inhibitor targeting BCR-ABL1, approved for CML treatment, particularly in patients with the T315I mutation.
More Related Videos
06:54A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
05:19A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis III: Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies